A 2024 study in Scientific Reports found that glucagon-like peptide 1 GLP-1 drugs show a link to a significantly higher risk of depression, anxiety, and potential suicide, likely due to how the GLP-1 affects regions involved in mood and reward regulation
No room-temperature allowance should be assumed for retatrutide unless explicitly stated by the manufacturer or trial sponsor on the IMP label or in the trial protocol
Notably, a recent study in Croatia found that ibuprofen was the most common drug involved in accidental ingestions among young children
As demand for medications like Ozempic, Wegovy, and Mounjaro continues to grow, employers and wellness providers are evaluating how GLP-1s may impact workplace wellness programs, employee benefits strategies, engagement initiatives, and long-term population health outcomes